Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Acquisitions (2016 - 2023)

Historic Acquisitions for Bio-Techne (TECH) over the last 10 years, with Q4 2023 value amounting to $3.3 million.

  • Bio-Techne's Acquisitions changed N/A to $3.3 million in Q4 2023 from the same period last year, while for Mar 2025 it was $3.3 million, marking a year-over-year decrease of 9806.67%. This contributed to the annual value of $169.7 million for FY2024, which is 6772.12% up from last year.
  • Latest data reveals that Bio-Techne reported Acquisitions of $3.3 million as of Q4 2023.
  • Bio-Techne's 5-year Acquisitions high stood at $215.6 million for Q2 2021, and its period low was -$1000.0 during Q1 2019.
  • Its 4-year average for Acquisitions is $83.9 million, with a median of $59.2 million in 2019.
  • Within the past 5 years, the most significant YoY rise in Bio-Techne's Acquisitions was 51780.97% (2019), while the steepest drop was 10000.18% (2019).
  • Bio-Techne's Acquisitions (Quarter) stood at $17.2 million in 2019, then soared by 1152.98% to $215.6 million in 2021, then crashed by 53.07% to $101.2 million in 2022, then crashed by 96.76% to $3.3 million in 2023.
  • Its Acquisitions stands at $3.3 million for Q4 2023, versus $166.4 million for Q3 2023 and $101.2 million for Q3 2022.